Concepedia

Nalinie Joharatnam‐Hogan

NJ

13

Publications

621

Citations

12

H-Index

2019

Active since

Affiliations

University College London(Current)

Royal Marsden NHS Foundation Trust

University College London Hospitals NHS Foundation Trust

MRC Clinical Trials Unit at UCL

Institute of Cancer Research

Nalinie Joharatnam‐Hogan is an author at University College London specializing in medicine, oncology, and covid-19.

ORCID

Top concepts

Publications per year

2019–2023

13

Publications

13

Adaptive immunity and neutralizing antibodies against SARS-CoV-2 variants of concern following vaccination in patients with cancer: the CAPTURE study

Annika Fendler, Scott T.C. Shepherd, Lewis Au et al. · Nature Cancer · 2021 · 177 citations · Full text

Cytokine release syndrome in a patient with colorectal cancer after vaccination with BNT162b2

Lewis Au, Annika Fendler, Scott Shepherd et al. · Nature Medicine · 2021 · 98 citations · Full text

Functional antibody and T cell immunity following SARS-CoV-2 infection, including by variants of concern, in patients with cancer: the CAPTURE study

Annika Fendler, Lewis Au, Scott T.C. Shepherd et al. · Nature Cancer · 2021 · 88 citations · Full text

Aspirin as an adjuvant treatment for cancer: feasibility results from the Add-Aspirin randomised trial

Nalinie Joharatnam‐Hogan, Fay Cafferty, Richard Hubner et al. · ˜The œLancet. Gastroenterology & hepatology · 2019 · 63 citations · Full text

, , +7

Testing approaches to sharing trial results with participants: The Show RESPECT cluster randomised, factorial, mixed methods trial

Annabelle South, Nalinie Joharatnam‐Hogan, Cara Purvis et al. · PLoS Medicine · 2021 · 39 citations · Full text

Rows per page

1–5 of 13